Niger faces meningitis after Ebola Outbreak


A compound constructed by Niger on the outskirts of capital Niamey in anticipation of a doable Ebola outbreak might be used to take care of one other illness – meningitis.

Within the Lazaretto compound, employees have rolled up their sleeves to develop the positioning’s wards, whereas medical doctors have been relentlessly attending to dozens of sufferers who’ve are available for therapy.

“We anticipate to obtain extra sufferers; that’s the reason we’re finishing up expansions,” Emmanuel Massart, unit coordinator with the meningitis response program, instructed.

The Lazaretto website was initially supposed to accommodate doable instances of Ebola. It has now been reassigned, nonetheless, to obtain individuals affected by a meningitis outbreak that started in December.

In accordance with Massart, the complicated at the moment accommodates 200 beds out of an estimated 350 which can be wanted.

The necessity to develop the ability is highlighted by the variety of sufferers mendacity on the ground on plastic mats within the middle’s yards.

“Because the epidemic started, about 594 individuals have been obtained by the ability,” Issoufou Djibo, a well being official in Niamey’s District 3, instructed.

As of April 23, 48 deaths had been recorded within the Lazaretto middle, 281 had been discharged, and 165 had been nonetheless receiving care, he stated.

In the meantime, a vaccination marketing campaign is at the moment underway at main colleges.

At a Thursday press convention, Nigerien Well being Minister Mano Aghali stated that kids had been being focused in a nationwide vaccination marketing campaign however that obtainable doses of the vaccine had been “not ample to vaccinate all classes.”

The minister famous that, as of April 23, meningitis had prompted 129 deaths out of 1,150 instances recorded since December of final 12 months.

The federal government additionally determined to shut all colleges in Niamey for the previous week to “keep away from contagion.”

Be the first to comment

Leave a Reply

Your email address will not be published.